Significantly abnormal lipoprotein patterns were found in 20 per cent of the random sample and 40 per cent of the ischaemic heart disease group. Five types of abnormal SML profile were found (S, SM, MS, M, and ML), which corresponded to Fredrickson types IIa, IIb, IV, and V. The frequency distribution of these patterns was not significantly different in the random sample and ischaemic heart disease group.
Type IV hyperlipoproteinaemias (M+ML types) comprised 53 per cent of all abnormal patterns in the random sample and 57 per cent in the ischaemic heart disease group. Thirty-one per cent of abnormal patterns in both the random sample and ischaemic heart disease group were Type IIa (S type), and about I2 per cent ofabnormalpatterns in each group had an increased concentration of both Sf 0-20 and Sf 20-400 lipoproteins, Type IIb (SM+MS types).
In the random sample, Type IV hyperlipoproteinaemias were significantly more common in obese than in slim men, whereas in the ischaemic heart disease group there was a smaller non-significant difference between them. However, slim ischaemic heart disease patients had a 3 times greater prevalence of abnormal lipoprotein patterns compared with slim random sample subjects.
In recent years the diagnosis of hyperlipidaemia has been rationalized by resolving hypercholesterolaemias and hypertriglyceridaemias into one of six types of abnormal lipoprotein pattern (Fredrickson, Levy, and Lees, I967; World Health Organization, I970). Studies have been conducted in patients with genetically determined hyperlipoproteinaemias (Fredrickson et al., I968) , but the prevalence of the various types of abnormal pattern in different populations is virtually unknown, and there are, as yet, few studies in subjects with ischaemic heart disease.
In this paper we report the use of a simple, inexpensive method of lipoprotein analysis, i.e. membrane filtration and nephelometry (Stone and Thorp, I966; Stone et al., 1970) , to estimate the prevalence and distribution of abnormal lipoprotein patterns in a sample of U.K. men aged 30 to 69 years and in an age-matched group of patients with ischaemic heart disease. 
Subjects
The subjects of this investigation were 429 men aged 30 to 69 years from the industrial town of Leigh, Lancashire, and from the immediate surrounding area. Two groups of subjects were examined, (i) a general practice random sample and (2) a group of patients with ischaemic heart disease. i) General practice random sample A U.K. 'general practice' consists of people who have placed themselves under the care of a specific general practitioner in the area in which they live and have 'registered' this fact with the National Health Service administration for the area. A record envelope within which are recorded details of any illness suffered by the subject is held in the record files of their general practitioner. The record is sent to him when he first accepts responsibility for the subject, even though the latter may not suffer from any illness and may not even consult him.
2,800 subjects who had 'registered' with one of us (M.C.S.). The 'practice' had been under the care of this same general practitioner for i6 years at the time the study was begun. Alternate record envelopes were selected and marked at a single session from the complete record files of the practice; thereby a i in 2 sample of the practice records was obtained.
The records of those subjects who had not reached their I5th birthday on the day of selection were rejected, leaving 480 men and 534 women. All subjects were invited by letter, and later by personal interview, to take part in the study, part of which is reported here and part elsewhere (Stone et al., 1971; Dick and Stone, I973) . In the male group there were 322 subjects in the 30 tO 69 year age range. Only 283 of these subjects (88%) completed the standardized examination, which is described elsewhere (Dick and Stone, 1973) . Of the 39 subjects who were not examined, 2I refused examination, 13 left the area, and 5 died before they could be examined. The proportion of the subjects examined was about the same in each decade of age, the highest being 9I per cent in the 30 to 39 year group and the lowest 86 per cent in the 40 to 49 year group. The 283 subjects who completed the examination constitute the 'random sample' reported in this paper.
Clearly, a general practice sample is not necessarily representative of the entire population. However, in men the degree to which the sample represents the whole U.K. male population can be assessed by comparing the frequency distribution of i6 socioeconomic groups (General Register Office, I966) in the sample, with that found in the I966 U.K. sample census (General Register Office, I969). These socioeconomic groups are reported in some of the census tables as 7 categories. We have compared the frequency distribution of these 7 categories in all men aged IS years and over in our sample with that in the I966 U.K. sample census by calculation of x2 on the original numbers. We found no significant difference (P > o io) between the distributions.
The sample, as would be expected, contained some subjects with diseases known to their general practitioner and others in whom abnormalities were discovered at examination. For example, 2 subjects were known to have diabetes mellitus. One (aged 36 years) was receiving insulin and the other (aged 6i years) was on diet alone. Both were well controlled and had normal lipoprotein patterns at the time of examination. One patient aged 59 years had suffered from myxoedema but was well controlled on 0-3 mg/day of L-thyroxine sodium; he had a mild S type lipoprotein pattern at the time of examination.
Twenty-six of the subjects in the random sample (9.2%) had well-documented ischaemic heart disease.
Eight of these had angina pectoris and i8 had survived a myocardial infarction. Only one of these patients was in the 30 to 39 year age range, 3 were aged 40 to 49 years, II were 50 to 59 years old, and II were between 6o and 69 years. Five of these 26 patients had 'mild hyperlipoproteinaemia' and a further 6 had 'significantly abnormal' lipoprotein patterns, as defined later in this paper.
A further 8 subjects were apparently well at the time of the examination but had electrocardiographic abnormalities classified as definite or probable ischaemic heart disease (Dick and Stone, I973) , and 4 further subjects had suffered episodes of severe central chest pain, but no electrocardiographic or enzyme changes had occurred at the time of the attack. None of these I2 subjects had significantly abnormal lipoprotein patterns at the time of their examination. Data from the random sample reported in this paper include all of these subjects.
2) Male patients with ischaemic heart disease This group did not include any subjects from the random sample. It consisted of 146 subjects, I09 of whom had survived a myocardial infarction and 37 who were suffering from angina pectoris. None of these patients was suffering from diabetes mellitus. Those with myocardial infarction had been treated in hospital by one of us (T.B.S.D.), during the acute episode, and were reexamined more than 3 months later. Only subjects with definite evidence of myocardial infarction were included in this group, i.e. they had a typical history with a changing pattern in serial electrocardiograms (Dick and Stone, 1973) . Enzyme studies had been carried out on all of them, but no one was included unless he also had characteristic serial electrocardiographic abnormalities. Sixty-nine of the myocardial infarction patients were examined between 3 and I2 months after the acute episode, a further 25 between i and 3 years, and I5 between 3 and I2 years after infarction. All the patients who survived their myocardial infarctions for long enough to attend the medical outpatient clinic for surveillance, or who were referred to that clinic because of post-infarction angina, were examined in the Clinical Research Unit, i.e. all subjects available for examination are included.
After discharge from hospital each patient with myocardial infarction was advised to practise gradual mobilization within the limits of ordinary living. Fortyone subjects who were examined less than 6 months after infarction had been given no instructions as to diet and were not given any lipid-lowering drugs. Of the patients who were examined 6 months or more after the initial attack, some had lost weight at some time in the past, but their weight was stable at the time of their examination.
All of the 37 patients with angina pectoris had highly characteristic histories of praecordial pain on effort, assessed independently by each author, and had no history suggestive of myocardial infarction.
For at least 4 weeks before their lipoprotein analysis, all subjects in both the random sample and ischaemic heart disease groups had been on a 'normal' diet, were not losing weight, and were not taking any lipid-lowering medication.
Methods
Blood was drawn after a 14-hour overnight fast, following at least 4 weeks on the subject's accustomed diet. The concentrations of the lipoprotein fractions were estimated from the results of 'MNC analysis' (mem-brane filtration, nephelometry, and cholesterol estimation).
MNC analysis a) Serum total cholesterol (TC) was estimated by the method of Connerty, Briggs, and Eaton (I96I). The accuracy and reproducibility of the method is described elsewhere (Stone et al. 1970 Terminology and classification In an earlier publication (Stone et al., 1971) we have used the terms S particles, M particles, and L particles to mean small, medium, and large low density lipoproteins, i.e. beta lipoproteins (Sf 0-20), pre-beta lipoproteins (Sf 20-400), and chylomicrons (Sf > 400), respectively. The types of lipoprotein pattern were determined from the concentrations of these 3 fractions and were defined as 'significantly abnormal' if the concentrations of one or more fractions exceeded the ggth percentile levels found in a group of 2I6 healthy young subjects (Stone et al., I971) -mean age 23 years -none of whom is included in the present study. These lipoprotein concentrations which were called 'lower limits of significant abnormality', were at 550 mg/ioo ml for S particles, 240 mg/ioo ml for M particles, and 25 mg/ioo ml for L particles in male subjects. We calculated that a significant abnormality in S particles could occur only if the serum cholesterol concentrations exceeded 270 mg/1oo ml, and a significant abnormality in M particles could occur only if the triglyceride concentrations exceeded 200 mg/ioo ml.
In the present paper we have divided this 'significantly abnormal' group into 'moderately severe' and ' severe' as shown in the Fig. The cutting points between these degrees of abnormality (700 mg/ioo ml and 500 mg/ioo ml for S and M particles, respectively) were chosen so that a severe S type pattern would require a minimum cholesterol concentration of about 350 mg/IOO ml, and a severe M type pattern a minimum triglyceride concentration of about 400 mg/ioo ml (i.e. about twice as great as the minimum level required for entry into the 'moderately severe' M type category).
We also described (Stone et The dividing line between the SM and MS types was found by joining the concentrations of S and M particles having the same 'particle score' as described elsewhere (Stone et al., 1971 ).
reference group. This degree of abnormality is referred to in the present paper as 'mild hyperlipoproteinaemia' (Fig.) , and is defined by S particle concentrations between 500 and 550 mg/100 ml, or M particle concentrations between 200 and 240 mg/100 ml. We have calculated that a 'mild' S type pattern could occur only if the serum cholesterol concentration exceeded about 250 mg/100 ml and a 'mild' M type pattern only if the triglyceride concentrations exceeded about 165 mg/100 ml. The 'SML classification' of lipoprotein patterns based on MNC analysis, and using the 95th and 99th percentile cut-off levels defined above, was described fully elsewhere (Stone et al., 1971) . The abnormal lipoprotein patterns found in the present study were classified as described in the latter publication, but to simplify understanding of our results we have also converted the SML type patterns to the more familiar classification recommended in the recent World Health Organization memorandum (1970) . In the latter publication abnormal lipoprotein patterns are numbered I, IIa, IIb, III, IV, and V, following the system described by Fredrickson et al. (1967) . The relation between the SML and Fredrickson classifications has been discussed elsewhere (Stone et al., 1971) lipoproteins in the ischaemic heart disease group than in the random sample, and that the differences were greatest in the younger subjects. Table 2 shows the prevalence of 'mild' and 'moderate + severe' hyperlipoproteinaemias. The Table shows that the ischaemic heart disease group had a significantly greater prevalence of both Type IIa and Type IV patterns compared to the random sample. The age distribution of the random sample and ischaemic heart disease groups was similar (493±I0O4 SD v 5I9±8-3 SD, respectively). In the random sample no significant relation was found between age and the overall presence of hyperlipoproteinaemias, though there was a trend towards increased prevalence in the 40 to 49 year age group. In the ischaemic heart disease group, however, the hyperlipoproteinaemia prevalence was significantly greater in the 30 to 39-year-old group (8 of i0 patients) than in the 6o to 69-year-old group (8 of 30 patients) -P < o0os. The prevalence of the various types of hyperlipoproteinaemia reported by other authors using electrophoresis and chemical analysis is summarized in Table 3 for comparison with our results shown in Table 2 . Though abnormal patterns were twice as common in the ischaemic heart disease group as in the random sample, the frequency distribution of the various types of pattern was not significantly different (Table 4) .
Only i9 of the 429 subjects in this study (4.4%) had 'severe' hyperlipoproteinaemia (Fig.) . There were 9 subjects (3-2%) in the random sample (i Type IIa, 2 Type IIb, 4 Type IV, and 2 Type V patterns), and i0 patients (6-8%) in the ischaemic heart disease group (3 Type IIa, 2 Type IIb, and 5 Type IV patterns). None of these subjects had tendon xanthomas. Though the prevalence of severe hyperlipoproteinaemia was twice as great in the ischaemic heart disease group as in the random sample, this difference was not significant at the 5 per cent level.
There were 63 subjects with moderate or severe M or ML type patterns (corresponding to Type IV), 29 in the random sample and 34 in the ischaemic Two further random sample subjects had ML heart disease group. The serum cholesterol concen-type patterns in which the L particle concentration tration was < 250 mg/ioo ml in 37 (58 7%), between exceeded ioo mg/ioo ml, and were therefore con-250 and 300 mg/ioo ml in 25 (39 7%), and in one sidered to correspond to Type V patterns. Both of subject (ir6%) it exceeded 300 mg/Ioo ml. In the these subjects had hypercholesterolaemia (294 and 40 to 59-year-old subjects the mean serum choles-412 mg/Ioo ml). terol concentration was significantly higher in the Type IV patterns in the ischaemic heart disease Hyperlipoproteinaemia and obesity group (255 mg/IOO ml ± 25 I SD) than in the ran-We studied the relation between hyperlipoproteindom sample (234 ± 37-2 SD) -P < 0o05. aemia and subscapular skinfold thickness (SST) in Table 5 . Only slight differences were found in the range of SST in the corresponding tertiles of the random sample and ischaemic heart disease groups.
It can be seen from Table 5 that the prevalence of 'S predominant' hyperlipoproteinaemias (i.e.
those in which Sf 0-20 is the predominant fractionStone et al., I97I) was greater in obese than in slim random sample subjects, but this difference was not significant at the 5 per cent level. However, 'M predominant' patterns (i.e. MS + M + ML typesthe disorders of endogenous triglyceride transport) were significantly more common in obese than in slim subjects in the random sample, though not in the ischaemic heart disease group. Table 5 also shows a highly significant increase in the prevalence of hyperlipoproteinaemias in slim ischaemic heart disease subjects compared to their slim random sample counterparts (P < o.oos). However, in the obese subjects no significant difference in prevalence was found.
Hyperlipoproteinaemia in myocardial infarction and angina pectoris Because of suggested differences in lipoprotein concentrations between myocardial infarction and angina (Pilkington and Koerselman, I96I), we examined the prevalence of hyperlipoproteinaemias in these groups separately. The results are shown in Table 6 . The groups were similar in age and sub- Our random sample was drawn from a single general practice and could therefore be criticized on the grounds that it is not representative of U.K. men as a whole. However, our data suggest that in terms of socioeconomic groups, it is in fact a reasonably representative sample.
We have deliberately not excluded from our random sample those subjects with known or suspected ischaemic heart disease since one of our aims was to estimate the prevalence and distribution of hyperlipoproteinaemias in a population sample. We have, however, recalculated the prevalences after excluding these subjects and found virtually no differences compared with the results published in our tables.
There are certain difficulties in making valid comparisons between our results and those summarized in Table 3 . The 4 studies summarized in that Table 3 .
Despite these differences, the prevalence of hyperlipoproteinaemias in 'normals' in the first 3 studies summarized in Table 3 (I8-30%) is similar to that in our random sample (I9%), and the ratio, IHD prevalence , in the studies of Werko (I971) 'normal' prevalence and Leren and Haabrekke (I97Ia, b) , (2-4 and 2-5, respectively), is similar to our own (2 i). However, the difference in hyperlipoproteinaemia prevalence between our random sample and ischaemic heart disease groups is less than that reported by Heinle et al. (I969) between patients with angiographically determined coronary artery disease and those with normal coronary arteries (54% and ii% respectively), or by Patterson and Slack (I972) who found 22-4 and 4-6 per cent in ischaemic heart disease and controls, respectively.
It can be seen from Table 3 that studies in which electrophoresis and chemical estimation of cholesterol and triglycerides have been used differ from one another in the proportion of patterns assigned to Types II and IV, despite the use of similar 'upper limits of normal'. This difference could be ascribed in part to true population variation, but it seems probable that there are also some differences between the studies in the classification of lipoprotein pattems. (Table 5) .
If, for the purposes of comparison with the data in Table 3 , we assign all MS type patterns to Type IIb, and the 2 ML type patterns in which the L particle concentration exceeds ioo mg/Ioo ml, to Type V, then the prevalence of Type II hyperlipoproteinaemia in the present study was 8-5 per cent, that of Type IV I0-2 per cent, and Type V 0o7 per cent. Similarly, in our ischaemic heart disease group the prevalence of Type II was I7-2 and Type IV 23.3 per cent; there were no Type V patterns in our ischaemic heart disease group.
The relation which we found between obesity and lipoprotein concentrations (particularly M particles) was to be expected, since it has been shown in a prospective study (Harlan, Graybiel, and Osborne, I965) that the concentration of Sf I2-400 lipoproteins increased in subjects who gained weight.
Prevalence of hyperlipoproteinaemias 96I However, the greater prevalence of M predominant hyperlipoproteinaemia associated with ischaemic heart disease, cannot be attributed to obesity, since slim subjects with ischaemic heart disease had a three times greater prevalence of M predominant patterns than slim random sample subjects.
We found a low prevalence of severe hyperlipoproteinaemias in both random sample and ischaemic heart disease groups, for example, only 0o4 per cent of the random sample and 2-7 per cent of the ischaemic heart disease group had severe Type II patterns, with serum cholesterol concentrations greater than 350 mg/Ioo ml. It has been shown (Slack, I969) that men with genetically determined Type II hyperlipoproteinaemia have a greater risk of premature myocardial infarction and death than those with Types III, IV, and V. However, our random sample data suggest that the prevalence of such severe Type II patterns in U.K. men is very low.
In a prospective study, Kannel et al. (197I) found that the majority of hypercholesterolaemias which predisposed to coronary disease in the population were in the moderate range 250 to 350 mg/Ioo ml. However, hypercholesterolaemia is found with various types of abnormal lipoprotein pattern each of which may indicate a different underlying disorder of lipid transport or metabolism. In the present study all subjects with 'mild' and 'moderate' Type IIa + IIb patterns had serum cholesterol concentrations between 250 and 350 mg/Ioo ml, as did 2I per cent with 'mild' and 43 per cent with 'moderate + severe' Type IV/V patterns.
On the basis of the publications shown in Table  3 it appears difficult to compare the prevalence of different types of hyperlipoproteinaemia in population samples, even when the same method (e.g. electrophoresis) and the same cutting points for lipids are used. Our use of a different method of analysis and classification may at first sight appear to aggravate the situation. However, we justify our publication of these results on the grounds that (a) the method has been shown to provide reproducible analyses in different laboratories (Stone et al., I970) , (b) the data are expressed in quantitative terms, and (c) since the cutting points for each fraction are fixed, the SML classification of any particular sample is unequivocal. MNC 
